Scandinavian journal of public health · 2026
The Mother in Norway Study (MiNS): study protocol for a randomized controlled trial evaluating the effectiveness of the Nurse-Family Partnership home visiting programme.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pedersen Eirin, Finne Joakim, Malmberg-Heimonen Ira, Wiggen Kjersti Stabell, Nilsen Wendy, Skar Ane-Marthe Solheim, Fredriksen Eivor, Flaathen Eva Marie, Hagen Milada, Rotevatn Torill Alise, Øien Henning, Ekre Maria, Catherine Nicole L A, Tøge Anne Grete
Аннотация
AIMS: Since 2015, the Norwegian government has prioritized early prevention of social inequities and child maltreatment. As part of this, it has commissioned an evaluation of the Nurse-Family Partnership programme (NFP) adapted for Norway. NFP is a manualized, intensive nurse home-visiting programme to support families experiencing disadvantage from early pregnancy until the child is 2 years old.
METHODS: The Mother in Norway Study (MiNS) is a parallel-group randomized controlled trial evaluating the effectiveness of the NFP programme versus standard care in improving maternal and child outcomes. A total of 700 participants is being recruited between 2023 and 2026 at least 12 weeks before their due date, screened for eligibility, and individually randomly assigned (1:1) to standard care alone or NFP plus standard care. Both groups may access usual community services. Primary outcomes are maternal-reported intimate partner violence and child maltreatment risk, assessed at baseline and 24 months postpartum using the Composite Abuse Scale - Revised Short Form (CASr-SF) and the Brief Child Abuse Potential Inventory (BCAPI), respectively. Secondary outcomes include maternal mental health, parenting, child socioemotional development, parent-child interaction, and health-related outcomes assessed through questionnaires and linked administrative data. Analyses will follow the intention to treat principle, with statisticians blinded to allocation. Cost-effectiveness analyses will estimate the cost per quality-adjusted life year (QALY) gained.
CONCLUSIONS: This trial will generate evidence on the effectiveness and cost-effectiveness of the NFP in Norway, inform policymaking for early prevention of child health inequities, and establish a foundation for longer-term follow-up.
METHODS: The Mother in Norway Study (MiNS) is a parallel-group randomized controlled trial evaluating the effectiveness of the NFP programme versus standard care in improving maternal and child outcomes. A total of 700 participants is being recruited between 2023 and 2026 at least 12 weeks before their due date, screened for eligibility, and individually randomly assigned (1:1) to standard care alone or NFP plus standard care. Both groups may access usual community services. Primary outcomes are maternal-reported intimate partner violence and child maltreatment risk, assessed at baseline and 24 months postpartum using the Composite Abuse Scale - Revised Short Form (CASr-SF) and the Brief Child Abuse Potential Inventory (BCAPI), respectively. Secondary outcomes include maternal mental health, parenting, child socioemotional development, parent-child interaction, and health-related outcomes assessed through questionnaires and linked administrative data. Analyses will follow the intention to treat principle, with statisticians blinded to allocation. Cost-effectiveness analyses will estimate the cost per quality-adjusted life year (QALY) gained.
CONCLUSIONS: This trial will generate evidence on the effectiveness and cost-effectiveness of the NFP in Norway, inform policymaking for early prevention of child health inequities, and establish a foundation for longer-term follow-up.